IL155117A0 - Cyclic peptides, method for preparing same and use as angiogenesis inhibitor or activator - Google Patents

Cyclic peptides, method for preparing same and use as angiogenesis inhibitor or activator

Info

Publication number
IL155117A0
IL155117A0 IL15511701A IL15511701A IL155117A0 IL 155117 A0 IL155117 A0 IL 155117A0 IL 15511701 A IL15511701 A IL 15511701A IL 15511701 A IL15511701 A IL 15511701A IL 155117 A0 IL155117 A0 IL 155117A0
Authority
IL
Israel
Prior art keywords
activator
angiogenesis inhibitor
cyclic peptides
preparing same
angiogenesis
Prior art date
Application number
IL15511701A
Other languages
English (en)
Original Assignee
Commissariat Energie Atomique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Commissariat Energie Atomique filed Critical Commissariat Energie Atomique
Publication of IL155117A0 publication Critical patent/IL155117A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IL15511701A 2000-10-04 2001-10-02 Cyclic peptides, method for preparing same and use as angiogenesis inhibitor or activator IL155117A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0012654A FR2814744B1 (fr) 2000-10-04 2000-10-04 Cyclopeptides, leur procede de preparation et leur utilisation comme inhibiteur ou activateur de l'angiogenese
PCT/FR2001/003049 WO2002028895A2 (fr) 2000-10-04 2001-10-02 Cyclopeptides, leur procede de preparation et leur utilisation comme inhibiteur ou activateur de l'angiogenese

Publications (1)

Publication Number Publication Date
IL155117A0 true IL155117A0 (en) 2003-10-31

Family

ID=8854977

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15511701A IL155117A0 (en) 2000-10-04 2001-10-02 Cyclic peptides, method for preparing same and use as angiogenesis inhibitor or activator

Country Status (15)

Country Link
US (2) US7199100B2 (ja)
EP (1) EP1328546B1 (ja)
JP (1) JP4303958B2 (ja)
AT (1) ATE354589T1 (ja)
AU (2) AU9394801A (ja)
CA (1) CA2424506A1 (ja)
DE (1) DE60126802T2 (ja)
DK (1) DK1328546T3 (ja)
ES (1) ES2282293T3 (ja)
FR (1) FR2814744B1 (ja)
IL (1) IL155117A0 (ja)
NO (1) NO20031377L (ja)
NZ (1) NZ525069A (ja)
RU (1) RU2249599C2 (ja)
WO (1) WO2002028895A2 (ja)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7211240B2 (en) * 2002-03-01 2007-05-01 Bracco International B.V. Multivalent constructs for therapeutic and diagnostic applications
EP1587944A4 (en) 2002-03-01 2007-03-21 Dyax Corp KDR AND VEGF / KDR BINDING PEPTIDES AND THEIR USE FOR DIAGNOSTIC AND THERAPEUTIC PURPOSES
US8623822B2 (en) 2002-03-01 2014-01-07 Bracco Suisse Sa KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy
US7794693B2 (en) * 2002-03-01 2010-09-14 Bracco International B.V. Targeting vector-phospholipid conjugates
US7261876B2 (en) 2002-03-01 2007-08-28 Bracco International Bv Multivalent constructs for therapeutic and diagnostic applications
EP2284180B1 (en) 2003-03-03 2015-09-09 Dyax Corp. Uses of peptides that specifically bind HGF receptor (cMET)
EP1979370B1 (en) * 2006-01-17 2010-03-17 N.V. Organon SELECTIVE ENZYMATIC HYDROLYSIS OF C-TERMINAL tert-BUTYL ESTERS OF PEPTIDES
WO2008047370A2 (en) 2006-10-19 2008-04-24 Ramot At Tel Aviv University Ltd. Compositions and methods for inducing angiogenesis
US8741850B2 (en) * 2009-07-24 2014-06-03 Advanced Accelerator Applications S.A. Compounds modulators of VEGF activity and uses thereof
FR2969999B1 (fr) 2011-01-03 2013-02-08 Commissariat Energie Atomique Conjugue, son procede de preparation et ses utilisations
US9815867B2 (en) 2012-09-03 2017-11-14 The University Of Tokyo Peptide for inhibiting vascular endothelial growth factor receptor
CN103724290B (zh) * 2013-11-15 2015-04-29 浙江大学 一种环肽化合物clavatustide A及其产生菌、制备方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4310643A1 (de) * 1993-04-01 1994-10-06 Merck Patent Gmbh Cyclische Adhäsionsinhibitoren
EP0844252A3 (en) * 1996-11-15 1998-07-08 Remacle, José Cyclic peptides bearing a tail designed for subsequent chemical coupling and process for preparing same
EP1056773A2 (en) * 1998-02-11 2000-12-06 Resolution Pharmaceuticals Inc. Angiogenesis targeting molecules
AU776473C (en) * 1999-03-11 2005-04-14 Entremed, Inc Compositions and methods for treating cancer and hyperproliferative disorders

Also Published As

Publication number Publication date
EP1328546A2 (fr) 2003-07-23
WO2002028895A3 (fr) 2002-06-06
US20040092434A1 (en) 2004-05-13
USRE44022E1 (en) 2013-02-19
FR2814744B1 (fr) 2002-11-29
RU2249599C2 (ru) 2005-04-10
ATE354589T1 (de) 2007-03-15
NZ525069A (en) 2004-09-24
JP2004510784A (ja) 2004-04-08
JP4303958B2 (ja) 2009-07-29
NO20031377D0 (no) 2003-03-26
FR2814744A1 (fr) 2002-04-05
NO20031377L (no) 2003-05-02
ES2282293T3 (es) 2007-10-16
DE60126802D1 (de) 2007-04-05
AU2001293948B2 (en) 2005-11-03
DK1328546T3 (da) 2007-06-04
EP1328546B1 (fr) 2007-02-21
DE60126802T2 (de) 2007-11-08
WO2002028895A2 (fr) 2002-04-11
AU9394801A (en) 2002-04-15
US7199100B2 (en) 2007-04-03
CA2424506A1 (en) 2002-04-11

Similar Documents

Publication Publication Date Title
AU9394801A (en) Cyclic peptides, method for preparing same and use as angiogenesis inhibitor or activator
DK1210430T3 (da) MUC-1-afledte peptider
DE69713112T2 (de) Zusammensetzungen und methoden zur behandlung von infektionen unter verwendung von indolicidin-analogen
DE60142646D1 (en) Fusionprotein
HK1043537A1 (zh) 通過tie2受體激活劑調節血管通透性
ZA946872B (en) Enzyme inhibitors
MXPA03005218A (es) Peptidos y/o proteinas y uso de los mismos para la produccion de un medicamento terapeutico y/o profilactico.
HK1016090A1 (en) Bradykinin analogs as selective thrombin inhibitors
DE69804839D1 (de) Cd8 als inhibitor des zellulären immunsystems
AU7935494A (en) Bivalent thrombin inhibitors
AU3850997A (en) Immunologically active proteins of borrelia burgdorferi, coded nuclein acids of such and their use in test kits and vaccines
AU6378994A (en) Plant promoter, microorganisms and plant cells containing a unit for the expression of a protein of interest comprising said promoter
AU8198001A (en) Dermal for amino laevulinic acid
AU2001293948A1 (en) Cyclic peptides, method for preparing same and use as angiogenesis inhibitor or activator
AU1521500A (en) Inhibition of angiogenesis by peptide analogs of high molecular weight kininogendomain
NZ511618A (en) Kininogen fragment 2 peptides with the formula of at least X-His-Lys-X-Lys-X
CO5271650A1 (es) Peptidos modificados y peptidomimeticos para el uso en inmunoterapia
DK0853484T3 (da) Hidtil ukendte MU-opioid-receptorligander: agonister og antagonister
ATE283914T1 (de) Iga1-protease fragment als trägerpeptid
NZ511166A (en) Genes that increase the production of HMG-CoA reductase inhibitor, ML-236B
GB9901710D0 (en) Peptide inhibitors
GB2361923A (en) Novel protein
EP1362915A4 (en) NOMURAEAE RILEYI -ORIGINE ECDYSTEROID 22-OXIDASE AND SYSTEM FOR HORMONE INACTIVATION MADE THROUGH THE USE OF SAID OXIDASE
DE60039511D1 (de) Tapetum-spezifische promotoren
MX9709921A (es) Alfa-d-galactosidasas de glicina y phaseolus.